Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Prurigo”

56 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 56 results

Testing effectiveness (Phase 2)Study completedNCT00507832
What this trial is testing

Evaluation of the Antipruritic Effect of Elidel (Pimecrolimus) in Non-atopic Pruritic Disease

Who this might be right for
Prurigo Nodularis
University Hospital Muenster 30
Testing effectiveness (Phase 2)Looking for participantsNCT07236099
What this trial is testing

Study of the Efficacy and Safety of ICP-332 in Participants With Prurigo Nodularis

Who this might be right for
Prurigo Nodularis (PN)
Beijing InnoCare Pharma Tech Co., Ltd. 135
Not applicableStudy completedNCT06427122
What this trial is testing

Effect of EMD Protocol for Urge on Dermatology-specific Quality of Life

Who this might be right for
Atopic DermatitisPrurigo Nodularis
Tamar Nijsten 96
Large-scale testing (Phase 3)Looking for participantsNCT06516965
What this trial is testing

Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With Prurigo Nodularis (STOP-PN2)

Who this might be right for
Prurigo Nodularis
Incyte Corporation 330
Post-approval studies (Phase 4)Looking for participantsNCT06773403
What this trial is testing

Upadacitinib for Prurigo Nodularis

Who this might be right for
Prurigo Nodularis
Psoriasis Treatment Center of Central New Jersey 25
Not applicableLooking for participantsNCT05316805
What this trial is testing

China Type II Inflammatory Skin Disease Clinical Research and Standardized Diagnosis and Treatment Project

Who this might be right for
Atopic Dermatitis EczemaPrurigo Nodularis
Peking University First Hospital 100,000
Not applicableLooking for participantsNCT07055009
What this trial is testing

Multi-centred Clinico-genetic Study of Actinic Prurigo in Thailand

Who this might be right for
Actinic Prurigo
Chulalongkorn University 47
Large-scale testing (Phase 3)Active Not RecruitingNCT06424470
What this trial is testing

Study on the Treatment of Prurigo Nodularis With Stapokibart Injection

Who this might be right for
Prurigo Nodularis
Keymed Biosciences Co.Ltd 200
Large-scale testing (Phase 3)Ended earlyNCT03540160
What this trial is testing

Study of the Long Term Safety of Serlopitant for the Treatment of Pruritus (Itch)

Who this might be right for
PruritusPrurigo NodularisAtopic Dermatitis+1 more
Vyne Therapeutics Inc. 558
Testing effectiveness (Phase 2)Active Not RecruitingNCT06994520
What this trial is testing

Efficacy of Topical Cannabidiol for Eczema

Who this might be right for
Chronic PruritusEczemaNummular Eczema+2 more
Khon Kaen University 60
Testing effectiveness (Phase 2)Study completedNCT05038982
What this trial is testing

Efficacy of Abrocitinib for Reducing Pruritus in Adults With Prurigo Nodularis and Chronic Pruritus of Unknown Origin

Who this might be right for
Prurigo NodularisPruritusChronic Pruritus+2 more
Johns Hopkins University 20
Testing effectiveness (Phase 2)Study completedNCT02196324
What this trial is testing

Placebo-Controlled Study of the Neurokinin-1 (NK1) Receptor Antagonist Serlopitant Prurigo Nodularis (PN)

Who this might be right for
Prurigo Nodularis
Vyne Therapeutics Inc. 128
Large-scale testing (Phase 3)Study completedNCT03497975
What this trial is testing

PRISM Study-Pruritus Relief Through Itch Scratch Modulation

Who this might be right for
Prurigo Nodularis
Trevi Therapeutics 353
Large-scale testing (Phase 3)Study completedNCT05764161
What this trial is testing

Evaluate the Efficacy and Safety of Ruxolitinib Cream in Participants With Prurigo Nodularis (PN)

Who this might be right for
Prurigo Nodularis
Incyte Corporation 190
Early research (Phase 1)Study completedNCT04944862
What this trial is testing

CDX-0159 in Patients With Prurigo Nodularis

Who this might be right for
Prurigo Nodularis
Celldex Therapeutics 24
Testing effectiveness (Phase 2)Study completedNCT01963793
What this trial is testing

Topical Aprepitant in Prurigo Patients

Who this might be right for
Pruritus
LEO Pharma 20
Not applicableStudy completedNCT04193670
What this trial is testing

Sensory Nociceptive Nerve Fibers, Key Regulator of Immune Response Type 2 in Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
University Hospital, Toulouse 18
Testing effectiveness (Phase 2)Study completedNCT03816891
What this trial is testing

Study to Assess the Efficacy, Safety, and Tolerability of Vixarelimab in Reducing Pruritus in Prurigo Nodularis

Who this might be right for
Prurigo NodularisPruritis
Genentech, Inc. 240
Large-scale testing (Phase 3)Study completedNCT05755438
What this trial is testing

Evaluate the Safety and Efficacy of Ruxolitinib Cream in Participants With Prurigo Nodularis (PN)

Who this might be right for
Prurigo
Incyte Corporation 204
Large-scale testing (Phase 3)Study completedNCT03677401
What this trial is testing

Study of the Efficacy, Safety and Tolerability of Serlopitant for the Treatment of Pruritus (Itch) With Prurigo Nodularis

Who this might be right for
PruritusPrurigo Nodularis
Vyne Therapeutics Inc. 295
Load More Results